Pharmafile Logo
Pharmafocus logo
Advanced Search

NHS

Showing 15 posts of 1107 posts found.

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026
Medical Communications MHRA, NHS, NICE, Wellcome, digital technologies, medical communications, mental health

The potential benefits of digital mental health technology for managing depression, anxiety and stress, together with other forms of care, …

Feature

A community-first future: which pathways will get us there?

November 21, 2025
Business Services Gateway to Local Adoption, NHS, Visions4Health, pharmacy

In the final Gateway to Local Adoption article of 2025, Visions4Health caught up with Julian Wenman, senior operations manager in …

Feature

The Pharma Files: with Dr Ewen Cameron, Chief Executive of West Suffolk NHS Foundation Trust

November 3, 2025
Medical Communications, Research and Development Corporate, NHS, The Pharma Files, healthcare professionals, patient care, patients

Pharmafile chats with Dr Ewen Cameron, Chief Executive of West Suffolk NHS Foundation Trust, about the best parts of his …

Feature

Is this an Oppenheimer moment for the life sciences industry?

October 29, 2025
Business Services, Market Access, Market Access Consultancy, Sales and Marketing NHS, Visions4Health

By Sabina Syed, Managing Director at Visions4Health In the history of science, few initiatives demonstrate the magnitude of coordinated effort …

Feature
Thought Leadership

Turning a 10-Year Vision into a 10-Year Plan

October 27, 2025
Business Services, Market Access, Market Access Consultancy Corporate, Gateway to Local Adoption, NHS, Pharmacy, Population Health Management, Visions4Health, pharmacy

In the sixth of the Gateway to Local Adoption series, Visions4Health’s Head of Client Services, Jonny Savage, shares his views …

Feature
covid_cell

COVID-19 vaccine eligibility creates challenges for UK pharmacies

October 8, 2025
Medical Communications COVID-19, NHS, pharmacies, vaccinations

Pharmacists across England have reported widespread confusion among patients attempting to book COVID-19 vaccination appointments despite no longer meeting the …

News

From sickness to prevention: the case for population health management

October 3, 2025
Business Services, Market Access, Market Access Consultancy Corporate, Gateway to Local Adoption, NHS, Pharmacy, Population Health Management, Visions4Health, pharmacy

In the third of the Gateway to Local Adoption series, Visions4Health caught up with James Scott, Digital and Informatics Specialist …

Feature

From Vaccine Innovation Pathway to growth powerhouse: how the UK is transforming clinical trials

October 2, 2025
Business Services, Market Access, Market Access Consultancy, Sales and Marketing 10 Year Health Plan, Life Sciences Sector Plan, NHS, National Institute for Health and Care Research, Pharmacy, UK Vaccine Innovation Pathway

Commercial clinical trials are a high-value growth driver for a country’s health and the economy and a key component of …

Feature
Thought Leadership

Combination treatments: Takeda’s Implementation Framework and the broader landscape

September 23, 2025
Research and Development HIV/AIDS, Hepatology, NHS, NICE, Oncology, Takeda, combination therapy, oncology

Pharmafile talks to Emma Roffe, Oncology Country Head (UK & Ireland) about the combination treatment landscape and the impact of …

Feature

The UK’s Life Sciences Sector Plan: a fresh launchpad or a continued labyrinth for the uptake of innovative medicines?

August 27, 2025
Business Services, Market Access, Market Access Consultancy, Sales and Marketing NHS, Visions4Health

As the UK healthcare system navigates a period of significant change, the path to successful market access is becoming increasingly …

Feature
Thought Leadership

Single national formulary and community care: a closer look at the 10-Year Health Plan

August 21, 2025
Business Services, Market Access Gateway to Local Adoption, NHS, Visions4Health

In the fourth of the Gateway to Local Adoption series, Visions4Health caught up with Frances Smith, Clinical Pharmacy Services Manager, …

Feature
az_vaccine

Rollout of world-first gonorrhoea vaccine programme begins under NHS

August 8, 2025
Medical Communications 10 Year Health Plan, Genito-Urinary system, Infections and infestations, NHS, gonorrhoea, sexual health, sexually transmitted infections, vaccination

From 4 August, sexual health clinics in England have been able to offer a free vaccine – the 4CMenB vaccine …

News
hospital

Sanome’s AI tool gains certification for early detection of hospital infections

August 7, 2025
Business Services, Research and Development AI, Devices, Infections and infestations, Medicines and Healthcare products Regulatory Agency, NHS, Sanome, hospital-acquired infections

Sanome’s MEMORI, an artificial intelligence (AI) medical device that can predict hospital-acquired infections up to 72 hours before they present, …

News

Key strategies to foster digital transformation in the NHS

July 30, 2025
Business Services, Market Access, Market Access Consultancy Corporate, Gateway to Local Adoption, NHS, Pharmacy, Visions4Health, digital transformation, pharmacy

In the third of the Gateway to Local Adoption series, Visions4Health caught up with James Scott, Digital and Informatics Specialist …

Feature

NICE approves AstraZeneca’s dual immunotherapy for advanced liver cancer

July 30, 2025
Medical Communications, Research and Development AstraZeneca, NHS, National Institute for Health and Care Excellence, Oncology, dual immunotherapy, hepatocellular carcinoma, liver cancer

AstraZeneca has received a positive recommendation from the National Institute for Health and Care Excellence (NICE) for its dual immunotherapy …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026